Showing 20 of 24 recruiting trials for “ulbright-hodes-syndrome”
RecruitingNCT07372170 ↗
Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic APS Patients
👨⚕️ Anabel Franco-Moreno, MD, PhD, Sociedad Española De Medicina Interna📍 2 sites📅 Started Dec 2025View details ↗
Prevalence and Consequences of Antiphospholipid Syndrome in Patients Aged 65 and Over With Ischemic Strokes (IS)
Evaluation of Cell Membrane Expression of Annexin A2 on Monocytes by Flow Cytometry in Primary Antiphospholipid Syndrome
Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
👨⚕️ Sponsor Chugai Pharmaceutical Co.Ltd, clinical-trials@chugai-pharm.co.jp📍 54 sites📅 Started Dec 2024View details ↗
RecruitingNCT06373003 ↗
Negative Antiphospholipid Syndrome: a Multicentric Study
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
👨⚕️ Sponsor Chugai Pharmaceutical Co.Ltd, clinical-trials@chugai-pharm.co.jp📍 67 sites📅 Started Aug 2024View details ↗
Effect of Belimumab on Antibody Titers in Primary APS Patients
Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin As Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE
👨⚕️ Seung-Hoon Lee, MD, PhD, Seoul National University Hospital📍 32 sites📅 Started Feb 2024View details ↗
Anti-CD38 Antibody Treating APS With Thrombocytopenia
👨⚕️ Lei Zhang, MD, Chinese Academy of Medical Science and Blood Disease Hospital📍 1 site📅 Started Aug 2023View details ↗
Daratumumab in Primary Antiphospholipid Syndrome
👨⚕️ Doruk Erkan, M.D., M.P.H., Hospital for Special Surgery, New York: Division of Rheumatology📍 8 sites📅 Started May 2023View details ↗
RecruitingNCT05679206 ↗
Antiphospholipid Syndrome and Postpartum Pulmonary Artery Pressure
RecruitingNCT05786235 ↗
Patients Pregnant Women With or Without Primary Antiphospholipid Antibody Syndrome
Enrolling by InvitationNCT05583305 ↗
Prevalence and Etiologies of Intracranial Stenosis in Patients With Antiphospholipid Syndrome
👨⚕️ Bonaventure Yiu Ming IP, MB ChB, Chinese University of Hong Kong📍 1 site📅 Started Oct 2022View details ↗
RecruitingNCT05230017 ↗
Chinese AntiphosPholipid Syndrome cohorT cOllaborative NEtworks
👨⚕️ Jiuliang Zhao, M.D., Peking Union Medical College Hospital📍 18 sites📅 Started Oct 2022View details ↗
RecruitingNCT05646394 ↗
Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS
👨⚕️ Cary Clark, International Society on Thrombosis and Haemostasis📍 3 sites📅 Started Jul 2022View details ↗
Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia
👨⚕️ Lei Zhang, MD, Chinese Academy of Medical Science and Blood Disease Hospital📍 2 sites📅 Started Jan 2022View details ↗
RecruitingNCT04308564 ↗
Laboratory and Clinical Data in Antiphospholipid Patients
RecruitingNCT04262492 ↗
International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants
RecruitingNCT07178925 ↗
Follow-up Cohort of Patients With Antiphospholipid Syndrome
RecruitingNCT03890601 ↗
New Biological Tests in Patients With Antiphospholipid Antibodies
Page 1 of 2Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →